BRIEF-Rallybio Corp - Candid Terminates Merger Agreement With Rallybio On May 3, 2026

BRIEF-Rallybio Corp - Candid Terminates Merger Agreement With Rallybio On May 3, 2026 - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Rallybio Corp - Candid Terminates Merger Agreement With Rallybio On May 3, 2026 - SEC Filing

May 4, 2026 5:15 AM

May 4 (Reuters) - Rallybio Corp ( RLYB ):

* RALLYBIO CORP ( RLYB ) - CANDID TERMINATES MERGER AGREEMENT WITH

RALLYBIO ON MAY 3, 2026 - SEC FILING

* RALLYBIO CORP ( RLYB ) - ENTITLED TO $50 MILLION PARENT TERMINATION

FEE - SEC FILING

* RALLYBIO CORP ( RLYB ) - CANDID TO PAY $50 MILLION TERMINATION FEE

PLUS $375,000 IN FEES TO RALLYBIO - SEC FILING

Source text:

Further company coverage:

Previous page： Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose Next page： Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose

Oct 17, 2025

09:29 AM EDT, 10/17/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Friday that a new post-hoc analysis of a late-stage study showed clinically meaningful improvements in tardive dyskinesia symptoms in patients treated with Ingrezza at the lowest available dose of 40 mg. The company said 90% of participants who received continuous treatment for 48 weeks improved by at...

Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation

Oct 17, 2025

TORONTO, Oct. 17, 2025 /PRNewswire/ -- Visionary Holdings Inc. ( GV ) , a Nasdaq-listed enterprise, announced today that it has completed the equity adjustment of Sikang (Guangzhou) Health Industry Investment Co., Ltd. (hereinafter referred to as the Joint Venture Company), a joint venture established with Guangzhou Sikang Investment Holding Co., Ltd. (hereinafter referred to as Guangzhou Sikang), and officially...

OBOOK Shares Fall Pre-Bell After Nasdaq Listing

Oct 17, 2025

09:27 AM EDT, 10/17/2025 (MT Newswires) -- OBOOK ( OWLS ) shares were down 38% in Friday premarket activity, continuing their losses after the company's Nasdaq listing on Thursday. The company's shares closed at $55.55 on Thursday, down 18% from their $68 per share opening price. The company said that at the closing price on Thursday its market capitalization was...

AbbVie Closes Bretisilocin Acquisition

Oct 17, 2025

09:28 AM EDT, 10/17/2025 (MT Newswires) -- AbbVie ( ABBV ) said Friday it has closed the acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate bretisilocin. Bretisilocin is a psychedelic compound in phase 2 clinical development for the treatment of patients with moderate to severe major depressive disorder, AbbVie ( ABBV ) said. ...